Bayer Consumer Health Division signed a strategic partnership agreement with the Shandong Institute for Food and Drug Control ...

After months of deliberation, and no formal offers from a buyer, Novartis has decided that its generics business Sandoz will be spun out into an independent company. The Swiss pharma group said ...

The $16 billion dollar 'asset swap' deal between GlaxoSmithKline (GSK) and Novartis has been formally ... of Pfizer's decision to sell its consumer health division to J&J a decade ago, one that ...

The global vitamin and mineral market is estimated to be valued at USD 24.5 billion. Global sales of vitamins and minerals ...

It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments ... is headquartered in Paris, France. Novartis AG engages in the research, development, manufacture, and marketing of ...

The global diabetic macular edema market is on a steady growth trajectory, with an expected valuation of approximately USD 4,120.9 million in 2024. The market is poised to surpass USD 4,642.9 million ...

Novartis (NVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Steve Scala from ...

Novartis is paying $150 million for a closer look at Schrödinger’s catalog of programs. The Big Pharma will work with Schrödinger to advance some of the computing-enabled R&D shop’s discovery programs ...

Hidradenitis suppurativa (HS) is a relatively common skin disease, affecting as many as one percent of people worldwide. But ...